Company intelligence / Profile preview
ReCerise Therapeutics
Seoul, Seoul Special City, South Korearecerise.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ReCerise Therapeutics is a South Korean biotech company established in 2020. It focuses on developing first-in-class/best-in-class targeted therapies for refractory cancers—especially liver cancer—and immune-metabolic diseases. The company leverages proprietary multiomics technology to identify novel drug candidates targeting previously undruggable molecules. Its current pipeline is preclinical, with ongoing government-supported projects aimed at advancing these programs toward clinical validation by 2028[1][2][3][4][5].
- Therapeutic areas
- ImmunologyOncologyGastroenterology
- Modalities
- Small moleculePeptides (inferred from participation in peptide therapy summits[6])
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Government partnerships/grants with the Ministry of Trade, Industry and Energy of South Koreaselected as part of the 'Baby Unicorn 200 Nurturing Project' by the Ministry of SMEs and Startups[5]
Beyond the preview
Go deeper on ReCerise Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReCerise Therapeutics.